Codis, a global contract development and manufacturing organization (CDMO) specializing in spray drying, amorphous solid dispersions (ASDs), and advanced particle engineering solutions, announces an agreement with Catalent Pharma Solutions (“Catalent”) to acquire Catalent’s facility in Nottingham, UK. The acquisition, expected to close in Q3 of this year subject to customary closing conditions, will add oral solid dose (OSD) development and small-scale manufacturing capabilities and create Europe’s leading single partner path for integrated spray dry solutions, from development through clinical supply and commercial intermediates, to final oral dose forms.
Read the full article: Codis to Acquire Catalent’s Nottingham, UK Facility to Create Europe’s Leading End-to-End Spray Dry Capability //
Source: https://www.prnewswire.com/news-releases/codis-to-acquire-catalents-nottingham-uk-facility-to-create-europes-leading-end-to-end-spray-dry-capability-302817224.html